Pramiracetam(Pramistar) is a central nervous system stimulant and nootropic agent discovered by scientists at Parke-Davis and marketed by Menarini as a treatment for memory and attention deficits in aging people
Pramiracetam is a central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. It is marketed by Menarini under the brand name Pramistar as a treatment for memory and attention deficits in aging people with neurodegenerative and vascular dementias in Italy and some Eastern European countries. Pramiracetam was discovered by scientists at Parke-Davis, at that time a division of Warner-Lambert, in the late 1970s; patents expired in 1996. 
